In France, there will be a gathering of French and European health innovation companies, international investors and leading pharmaceutical firms
France Biotech, the main professional association representing French health entrepreneurs, will gather the entire innovation ecosystem by launching the HealthTech Investor Day, an international event which will be held in Paris on June 25, 2019.
This event will bring together French and European HealthTech leaders (biotech, medtech, e-health, etc.), large pharmaceutical companies and international investors in health innovation.
This first event will take place on Tuesday 25th June at the Peninsula Hotel, Paris, under the Patronage of Mr Emmanuel Macron. Also in attendance will be the partnership of key players from the health innovation ecosystem including BDC Lifesciences, Bpifrance, Business France, Sofinnova Partners, Financière Arbevel, LEEM (Les Entreprises du Médicament), as well as pharmaceutical companies, such as Ipsen and Servier.
The French competitiveness clusters that will support the event are:
- LIR (Association des Laboratoires Internationaux de Recherche),
- Euronext
- Société Générale
- ODDO BHF
- EBE (European Biopharmaceutical Enterprises)
- EuropaBio
- EIT Health
- IREFI (Institute for French-Italian Economic Relations)
Various other partners and supports are expected to join France Biotech to promote the HealthTech sector.
Nearly 1,500 SMEs and start-up companies are attempting to invent and shape the future of medicine in France.
With the HealthTech Investor Day, France Biotech aims to strengthen this promising and dynamic ecosystem by turning Paris into the European stronghold for funding innovative health technologies.
France Biotech has chosen to organize the event in Paris in an effort to support French and European companies through their second round of financing, which can be difficult to achieve.
This event is dedicated to mature HealthTech companies that have already raised significant funds.
For medtech companies, medical devices must have already obtained the CE marking in Europe or FDA (Food and Drug Administration) approval in the United States. The challenge is the same for all companies: to spark the interest of leading investors in the sector.
French competitiveness clusters, such as large and small companies, research laboratories and educational institutions working together to develop synergies and innovative joints projects. They will relay a call for expressions of interest with the organizational support of Medicen Paris Région, the competitiveness cluster for innovative health technologies in the Paris region.
It will feature one-on-one meetings with health innovative entrepreneurs, investors, and leading pharmaceutical firms in addition to roundtables focused on economic and political issues related to tomorrow’s medicine.
The details about the roundtables and their moderators will be announced subsequently.
Maryvonne Hiance, Chairman of France Biotech, said:
“France Biotech is pleased to give European HealthTech companies a unique opportunity to meet international investors in France. This HealthTech Investor Day is a testament of our commitment to support health innovation SMEs and start-up companies, which have managed to get off the ground, but are struggling to find new investors to make their innovations available to patients.
By organizing this day in France, we want to highlight the dynamism and value of the French and European companies striving to invent tomorrow’s medicine.”
